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Abstract
● AIM: To evaluate and compare the clinical outcomes 
with a diffractive bifocal and trifocal intraocular lens (IOL) 
during a 12-month follow-up.
● METHODS: Prospective comparative study including 
75 eyes of 38 patients (44-70y) undergoing uneventful 
cataract surgery. Each patient was randomly assigned 
to one type of IOL, bifocal (35 eyes) or trifocal (40 eyes). 
Visual, refractive, and contrast sensitivity changes were 
evaluated in a 12-month follow-up. The binocular defocus 
curve was also measured at 12mo postoperatively.
● RESULTS: No statistically significant differences 
between groups were found in postoperative uncorrected 
and corrected distance visual acuities (P≥0.276). Postoperative 
corrected near visual acuity (33 cm) was significantly 
better in the trifocal group during all follow-up (P≤0.004) as 
well as 6-month uncorrected near (P=0.008) and distance-
corrected near visual acuities (P=0.016) (33/40 cm). 
Significantly better uncorrected intermediate and distance 
corrected-intermediate visual acuity were found during 
all follow-up in the trifocal group (P<0.001), which was 
consistent with differences among groups in binocular 
defocus curve. Differences among groups in contrast 
sensitivity were minimal, being only significant at 6 months 
for some low to medium spatial frequencies (P≤0.006). 
● CONCLUSION: Bifocal and trifocal diffractive IOLs are 
able to provide an effective visual restoration which is 
maintained during a 12-month follow-up, with a clear 
benefit of the trifocal IOL for the intermediate vision.
● KEYWORDS: trifocal intraocular lens; bifocal intraocular 
lens; defocus curve; contrast sensitivity; cataract surgery
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INTRODUCTION
S ome previous research has demonstrated that trifocal diffractive intraocular lenses (IOLs) are an effective 
option to restore the distance, intermediate and near visual 
function after cataract surgery[1-11]. This type of IOLs has been 
shown to be superior to previous bifocal diffractive IOLs 
in terms of intermediate visual outcome in some clinical 
comparative studies[12-14] and optical bench experiences[15-16]. 
Similarly, trifocal IOLs have shown their benefit in 
intermediate vision compared to apodized refractive-diffractive 
IOLs[17]. Our research group evaluated and compared the 
clinical outcomes with a diffractive bifocal and trifocal IOL 
of the same material and haptic design during a 3-month 
follow-up[14]. We concluded that diffractive trifocality provided 
an improved intermediate vision compared to diffractive 
bifocality, but maintaining similar levels of visual and ocular 
optical quality postoperatively. However, to this date, there 
is no comparative study of the visual performance achieved 
with a bifocal and trifocal diffractive IOL in a medium-
long term in order to confirm if the benefits of trifocality 
are maintained over time. The current study was aimed at 
evaluating and comparing the visual, refractive, and contrast 
sensitivity outcomes with a diffractive bifocal and trifocal IOL 
of the same material and with the same haptic design during a 
12-month follow-up.
SUBJECTS AND METHODS
Patients  This prospective comparative study included 75 
eyes of 38 patients with ages from 44 to 70y and undergoing 
uneventful cataract surgery with implantation of a bifocal or 
trifocal diffractive IOL. Each patient was randomly assigned 
to one type of implant, bifocal or trifocal. Accordingly, two 
groups were differentiated: bifocal group including 35 eyes of 
18 patients implanted with the IOL AT LISA 801 (Carl Zeiss 
Meditec, Jena, Germany), with a bifocal diffractive optics, and 
trifocal group including 40 eyes of 20 patients implanted with 
the IOL AT LISA tri 839MP, with a trifocal diffractive optics. 
Inclusion criteria were visually significant cataract, presbyopic/
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pre-presbyopic patients demanding refractive, and corneal 
astigmatism below 1.25 D. Exclusion criteria were previous 
ocular surgery, antecedents of glaucoma, ocular inflammation 
or retinal detachment, active ocular disease, irregular 
corneal astigmatism, abnormal iris, macular degeneration 
or retinopathy, and neurophthalmic disease. All patients 
were properly informed about their inclusion and signed an 
informed consent form. The study complied with the principles 
of the Declaration of Helsinki, and was approved by the Clinic 
Ethics Committee.
Examination Protocol  A complete opthalmologic examination 
was performed preoperatively including refraction, 
keratometry, monocular uncorrected distance visual acuity 
(UDVA) and corrected visual acuity (CDVA), monocular 
uncorrected imtermediate visual acuity (UIVA) and corrected 
intermediate visual acuity (CIVA) measured at 66 cm and 
80 cm, monocular uncorrected visual acuity (UNVA) and 
corrected near visual acuity (CNVA) measured at 33 cm and 40 cm, 
monocular distance-corrected near visual acuity (DCNVA) (33 
and 40 cm) and intermediate visual acuity (DCIVA) (66 and 80 cm),
Goldmann applanation tonometry, slit lamp examination, 
ocular aberrometry (OPD scan III, Nidek), corneal topography 
(OPD scan III, Nidek), biometry (IOL Master v.4.3, Carl Zeiss 
Meditec), and funduscopy. Visual acuities were measured using 
the Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
The following postoperative visits were scheduled: 1d, 1, 3, 6 
and 12mo after surgery. The same tests as preoperatively were 
done at 6 and 12mo after surgery, with the additional inclusion 
of the evaluation of photopic contrast sensitivity measurements 
(CSV-1000). Likewise, defocus curves were also obtained 
binocularly at 12mo postoperatively to evaluate the range 
of functional function using a methodology previously 
described[3,14], and the level of posterior capsular opacification 
(PCO) was evaluated in the central 4.3-mm zone using the 
EPCO 2000 software[18].
Intraocular Lenses  The AT LISA 801 (former Acri.LISA 
376 D) is a diffractive IOL made of a foldable hydrophilic 
acrylate (water content 25%) with the following main 
characteristics: single-piece with C-loop shape, diameter of the 
biconvex optical zone of 6.0 mm, total diameter of 12.5 mm, 
company labelled A-constant of 118.0, posterior lens surface 
asphericity of -0.18, haptic angulation of 0º, hydrophobic lens 
surface properties, and refractive index of 1.46. The theoretical 
addition provided by this IOL at the IOL plane is +3.75 D[14]. 
The AT LISA tri 839MP is a diffractive trifocal preloaded 
IOL made of the same material and with the same main 
characteristics. The main differences with the bifocal design 
are the following: total diameter of 11.0 mm, four-haptic 
design, 360º square edge to prevent PCO, trifocal diffractive 
pattern within an IOL diameter of 4.3 mm and bifocal pattern 
between 4.3 and 6 mm of diameter, and company labelled 
A-constant of 118.6. A near addition of +3.33 D is theoretically 
provided by the IOL as well as an intermediate addition of 
+1.66 D, both calculated at the IOL plane[14].
Surgery  The same experienced surgeon (Mojzis P) 
performed all surgeries using sutureless micro-coaxial 2.2-mm 
phacoemulsification when the bifocal IOL was implanted and a 
technique of microincision (1.8-mm) when the implanted IOL 
was the trifocal design. Before surgery, topical anaesthesia and 
mydriatic drops were instilled in all cases. Once performed 
the incision and paracentesis, the capsulorhexis was created 
and the phacoemulsification procedure was performed. After 
this, IOLs were inserted through the main incisions into the 
capsular bag using the AT.Shooter A1-2000 injector (Carl 
Zeiss Meditec) and Viscoject 2.2 cartridge when the bifocal 
IOL was implanted, and the BLUEMIXS 180 injector (Carl 
Zeiss Meditec) for the trifocal IOL. A combination of topical 
antibiotic and steroid was prescribed to be applied four times 
daily during one week as postoperative topical treatment.
Statistical Analysis  The statistical analysis was performed 
using the SPSS statistics software package 15.0.1 for Windows 
(IBM, Armonk, NY, USA). First, the normality of all data 
distributions was examined with the Kolmogorov-Smirnov 
test. The Student’s t-test for paired data was used to analyse all 
parameter comparisons between visits, and the Student’s t-test 
for unpaired data for the comparison between groups when 
data were normally distributed. In contrast, when data were not 
normally distributed, the Wilcoxon Rank Sum test was used to 
assess the significance of differences between examinations, 
and the Mann-Whitney test for comparing groups. The same 
level of significance (P<0.05) was considered in all cases.
RESULTS
Table 1 displays a comparison between bifocal and trifocal 
groups of preoperative data. As shown, no significant 
differences between groups were found in manifest cylinder, 
corneal astigmatism, keratometry, and UDVA, UIVA and 
UNVA (P≥0.076). However, IOL power was found to be 
significantly higher in trifocal group compared to bifocal group 
(P=0.017). 
Visual Acuity and Refractive Outcomes  Table 2 summarizes 
and compares the 6 and 12mo postoperative visual and 
refractive data in bifocal and trifocal groups. As shown, 
differences between groups in postoperative UDVA (6mo 
P=0.276; 12mo P=0.822) and CDVA (6mo P=0.334; 12mo 
P=0.487) were not statistically significant during the whole 
follow-up. In contrast, significant differences among groups 
were found in CNVA measured at 33 and 40 cm, with a 
significantly better visual outcome in the trifocal group 
(6mo P<0.001; 12mo P=0.004). Significant differences 
in UNVA (P=0.008) and DCNVA (P=0.016) measured at 
33 cm among groups were found at 6mo after surgery but 
not at 12mo postoperatively (UNVA P=0.529, DCNVA 
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P=0.627). Concerning near visual outcomes at 40 cm, 
significant differences were found among groups in CNVA 
during all follow-up, with the best outcome in the trifocal 
group (6mo P<0.001; 12mo P=0.004). Differences between 
groups in UNVA measured at 40 cm did not reach statistical 
significance (6mo P=0.053; 12mo P=0.857), whereas 
differences in DCNVA were only statistically significant at 
6mo postoperatively (P=0.023). Concerning intermediate 
vision, significant differences were found in UIVA and 
DCIVA at 6 and 12mo after surgery (P<0.001), with the best 
visual outcome observed in the trifocal group. No significant 
differences between groups in CIVA were detected during 
the postoperative follow-up (P≥0.241). A trend to a more 
significant myopic residual sphere (6mo P=0.056; 12mo 
P=0.007) and spherical equivalent (6mo P=0.004; 12mo 
P=0.005) was found in the bifocal group compared to the 
trifocal. Cylinder was significantly higher in the bifocal group 
compared to the trifocal group at 6mo (P<0.001), but not at 
12mo after surgery (P=0.538).
The improvement at 6mo in UDVA, CDVA, UNVA (33 and 
40 cm), DCNVA (33 and 40 cm), UIVA (66 and 80 cm), DCIVA 
(66 and 80 cm), and CIVA (80 cm) was statistically significant 
in the bifocal group (P≤0.046). In this same group, significant 
changes between 6 and 12mo after surgery were only detected 
in CIVA (66 cm) (P=0.010). In the trifocal group, a significant 
improvement at 6mo was detected in UNVA, UNVA (33 and 
40 cm), DCNVA (33 and 40 cm), CNVA (40 cm), and UIVA, 
CIVA and DCIVA measured at 66 and 80 cm (P≤0.007). 
Between 6 and 12mo after surgery, significant changes in 
CDVA, and in UNVA, CNVA and DCNVA measured at 33 cm 
were only detected in eyes implanted with the trifocal IOL.
Defocus Curve   Mean defocus curves obtained in bifocal 
and trifocal groups at 12mo after surgery are displayed in 
Figure 1. Significantly better visual acuity was found in the 
trifocal group compared to the bifocal group for the defocus 
levels of -1.00 (P<0.001) and -1.50 D (P=0.030). In contrast, 
the visual acuity for the defocus of -3.00 (P=0.045), -3.50 
(P=0.002) and -4.00 D (P=0.005) was significantly better in 
the bifocal group (Figure 1).
Contrast Sensitivity Outcomes  Mean contrast sensitivity 
function in bifocal and trifocal groups of eyes at 6 and 12mo 
postoperatively are displayed in Figure 2. Only statistically 
significant differences among groups were found in 6-month 
photopic contrast sensitivity values for the spatial frequency 
Table 1 Comparative table showing the preoperative clinical data of eyes included in the two groups 
Parameters
Bifocal group Trifocal group
P
Mean (SD) Median (Range) Mean (SD) Median (Range)
UDVA (logMAR) 0.57 (0.36) 0.50 (0.10 to 1.50) 0.54 (0.36) 0.40 (0.00 to 1.30) 0.665
CDVA (logMAR) 0.20 (0.31) 0.10 (-0.20 to 1.00) -0.03 (0.10) 0.00 (-0.20 to 0.20) <0.001
UNVA (logMAR, 33 cm) 0.73 (0.32) 0.70 (0.30 to 1.40) 0.81 (0.22) 0.90 (0.20 to 1.20) 0.205
CNVA (logMAR, 33 cm) 0.24 (0.27) 0.20 (-0.20 to 1.10) 0.05 (0.10) 0.00 (-0.20 to 0.20) <0.001
DCNVA (logMAR, 33 cm) 0.63 (0.24) 0.60 (0.10 to 1.40) 0.55 (0.19) 0.55 (0.20 to 0.90) 0.065
UNVA (logMAR, 40 cm) 0.76 (0.34) 0.70 (0.30 to 1.50) 0.81 (0.24) 0.85 (0.30 to 1.20) 0.319
CNVA (logMAR, 40 cm) 0.27 (0.30) 0.20 (0.00 to 1.50) 0.07 (0.12) 0.10 (-0.10 to 0.40) <0.001
DCNVA (logMAR, 40 cm) 0.62 (0.28) 0.60 (0.10 to 1.50) 0.56 (0.18) 0.60 (0.10 to 0.90) 0.357
UIVA (logMAR, 66 cm) 0.61 (0.36) 0.60 (0.00 to 1.50) 0.70 (0.30) 0.65 (0.20 to 1.30) 0.318
CIVA (logMAR, 66 cm) 0.17 (0.28) 0.10 (-0.20 to 1.10) -0.02 (0.10) 0.00 (-0.20 to 0.10) 0.001
DCIVA (logMAR, 66 cm) 0.41 (0.27) 0.30 (0.00 to 1.40) 0.26 (0.20) 0.30 (-0.10 to 0.80) 0.007
UIVA (logMAR, 80 cm) 0.60 (0.33) 0.60 (0.10 to 1.20) 0.63 (0.27) 0.60 (0.10 to 1.30) 0.728
CIVA (logMAR, 80 cm) 0.18 (0.27) 0.10 (-0.10 to 1.10) 0.01 (0.09) 0.00 (-0.20 to 0.20) 0.001
DCIVA (logMAR, 80 cm) 0.39 (0.24) 0.40 (0.00 to 1.10) 0.20 (0.20) 0.20 (-0.10 to 1.00) <0.001
Sphere (D) 0.43 (3.15) 0.75 (-7.25 to 9.00) 0.91 (2.96) 1.50 (-8.75 to 5.00) 0.030
Cylinder (D) -0.54 (0.56) -0.50 (-2.25 to 0.00) -0.34 (0.35) -0.25 (-1.25 to 0.00) 0.076
Spherical equivalent (D) 0.20 (3.12) 0.75 (-7.25 to 8.12) 0.75 (3.01) 1.38 (-8.75 to 4.88) 0.038
KM (D) 43.63 (1.86) 43.89 (40.59 to 47.64) 43.12 (1.71) 42.89 (39.71 to 46.88) 0.174
Corneal astigmatism (D) 0.56 (0.28) 0.53 (0.18 to 1.17) 0.58 (0.22) 0.58 (0.09 to 1.01) 0.413
AL (mm) 23.35 (1.26) 23.38 (19.23 to 25.31) 23.32 (1.57) 23.10 (21.05 to 28.09) 0.181
ACD (mm) 3.32 (0.36) 3.38 (2.48 to 3.85) 3.18 (0.33) 3.17 (2.55 to 4.05) 0.023
IOL power (D) 20.79 (4.02) 20.50 (12.50 to 33.00) 22.18 (4.79) 22.25 (11.50 to 29.50) 0.017
SD: Standard deviation; D: Diopters; IOL: Intraocular lens; UDVA: Uncorrected distance visual acuity; CDVA: Corrected distance visual 
acuity; UNVA: Uncorrected near visual acuity; DCNVA: Distance-corrected near visual acuity; CNVA: Corrected near visual acuity; UIVA: 
Uncorrected intermediate visual acuity; CIVA: Corrected intermediate visual acuity; DCIVA: Distance-corrected intermediate visual acuity; KM: 
Mean keratometry; AL: Axial length; ACD: Anterior chamber depth.
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of 3 cycles/degree (P=0.001) and 6-month mesopic contrast 
sensitivity values for the spatial frequencies of 6 (P=0.006) 
and 12 cycles/degree (P=0.014). In the bifocal group, only 
significant changes in contrast sensitivity were found for the 
values measured under mesopic conditions for the spatial 
frequencies of 3 (P=0.015) and 12 cycles/degree (P=0.006). 
In the trifocal group, the significant changes in contrast 
sensitivity occurred among 6 and 12mo postoperatively for 
the photopic values corresponding to the spatial frequencies of 
1.5 (P=0.018), 3 (P=0.041), 6 (P=0.011) and 18 cycles/degree 
(P=0.022) as well as for the mesopic values corresponding to 
the spatial frequency of 3 cycles/degree (P=0.044).
Complications  Mean EPCO scores at 12mo postoperatively 
were 0.49 (SD 0.67, median 0.21, range 0.00 to 3.00) and 0.33 
(SD 0.47, median 0.15, range: 0.00 to 2.02) in the bifocal and 
trifocal groups, respectively (P=0.506). A total of 4 (11.4%) 
and 3 eyes (7.5%) developed significant PCO in the bifocal 
and trifocal groups, respectively, and a YAG capsulotomy was 
required (P=0.560).
Table 2 Comparative table showing the 3-month postoperative clinical data of eyes included in the two groups                  Mean (SD)/median (range)
Parameters
Postoperative 6mo Postoperative 12mo
Bifocal group Trifocal group P Bifocal group Trifocal group P
UDVA 0.00 (0.10)/0.00 (-0.10 to 0.40) -0.03 (0.10)/0.00 (-0.20 to 0.20) 0.276 0.01 (0.13)/0.00 (-0.10 to 0.40) 0.02 (0.14)/0.00 (-0.20 to 0.40) 0.822
CDVA -0.02 (0.10)/0.00 (-0.20 to 0.40) -0.05 (0.08)/-0.05 (-0.20 to 0.10) 0.334 -0.01 (0.11)/0.00 (-0.20 to 0.40) 0.01 (0.12)/0.00 (-0.20 to 0.40) 0.487
UNVA (33 cm) 0.22 (0.10)/0.20 (0.10 to 0.50) 0.15 (0.13)/0.10 (-0.10 to 0.40) 0.008 0.19 (0.10)/0.20 (0.00 to 0.40) 0.21 (0.15)/0.20 (0.00 to 0.60) 0.529
CNVA ( 33 cm) 0.18 (0.08)/0.20 (0.10 to 0.40) 0.07 (0.07)/0.10 (-0.10 to 0.20) <0.001 0.19 (0.10)/0.20 (0.00 to 0.40) 0.12 (0.08)/0.10 (0.00 to 0.40) 0.004
DCNVA (33 cm) 0.21 (0.11)/0.20 (0.10 to 0.50) 0.15 (0.13)/0.10 (-0.10 to 0.40) 0.016 0.19 (0.11)/0.20 (0.00 to 0.40) 0.21 (0.15)/0.20 (0.00 to 0.60) 0.627
UNVA (40 cm) 0.27 (0.18)/0.30 (0.00 to 0.70) 0.20 (0.10)/0.20 (0.00 to 0.40) 0.053 0.25 (0.13)/0.30 (0.00 to 0.60) 0.25 (0.14)/0.20 (0.00 to 0.60) 0.857
CNVA (40 cm) 0.25 (0.16)/0.30 (0.00 to 0.60) 0.14 (0.08)/0.10 (0.00 to 0.30) <0.001 0.23 (0.12)/0.20 (0.00 to 0.50) 0.16 (0.08)/0.20 (0.00 to 0.40) 0.004
DCNVA (40 cm) 0.29 (0.18)/0.30 (0.00 to 0.70) 0.20 (0.10)/0.20 (0.00 to 0.40) 0.023 0.25 (0.13)/0.30 (0.00 to 0.60) 0.24 (0.14)/0.20 (0.00 to 0.50) 0.811
UIVA (66 cm) 0.27 (0.18)/0.30 (-0.10 to 0.60) 0.08 (0.09)/0.10 (-0.10 to 0.30) <0.001 0.26 (0.17)/0.30 (-0.10 to 0.70) 0.09 (0.11)/0.10 (-0.10 to 0.30) <0.001
CIVA (66 cm) 0.06 (0.10)/0.00 (-0.10 to 0.40) 0.06 (0.07)/0.10 (-0.10 to 0.20) 0.751 0.10 (0.12)/0.10 (-0.10 to 0.40) 0.07 (0.09)/0.10 (-0.10 to 0.30) 0.241
DCIVA (66 cm) 0.28 (0.16)/0.30 (-0.10 to 0.60) 0.08 (0.09)/0.10 (-0.10 to 0.30) <0.001 0.27 (0.17)/0.30 (-0.10 to 0.70) 0.08 (0.10)/0.10 (-0.10 to 0.30) <0.001
UIVA (80 cm) 0.23 (0.17)/0.20 (0.00 to 0.60) 0.07 (0.08)/0.10 (-0.20 to 0.20) <0.001 0.25 (0.18)/0.30 (-0.10 to 0.60) 0.08 (0.13)/0.05 (-0.10 to 0.40) <0.001
CIVA (80 cm) 0.06 (0.11)/0.00 (-0.10 to 0.40) 0.05 (0.08)/0.10 (-0.20 to 0.20) 0.749 0.05 (0.11)/0.00 (-0.10 to 0.40) 0.05 (0.10)/0.00 (-0.10 to 0.40) 0.906
DCIVA (80 cm) 0.24 (0.17)/0.30 (-0.10 to 0.60) 0.07 (0.08)/0.10 (-0.20 to 0.20) <0.001 0.26 (0.18)/0.30 (-0.10 to 0.60) 0.08 (0.13)/0.05 (-0.10 to 0.40) <0.001
Sphere (D) -0.16 (0.43)/0.00 (-1.00 to 1.00) 0.04 (0.36)/0.00 (-0.50 to 0.75) 0.056 -0.18 (0.47)/-0.25 (-1.25 to 1.25) 0.09 (0.39)/0.25 (-0.50 to 0.75) 0.007
Cylinder (D) -0.41 (0.26)/-0.50 (-1.00 to 0.00) -0.20 (0.19)/-0.25 (-0.50 to 0.00) <0.001 -0.37 (0.34)/-0.25 (-1.25 to 0.00) -0.31 (0.29)/-0.25 (-1.00 to 0.00) 0.538
Spherical 
equivalent (D) -0.36 (0.42)/-0.25 (-1.25 to 0.50) -0.06 (0.34)/-0.13 (-0.62 to 0.62) 0.004 -0.36 (0.46)/-0.38 (-1.38 to 0.75) -0.07 (0.35)/0.00 (-0.62 to 0.62) 0.005
Corneal 
astigmatism (D) 0.63 (0.38)/0.59 (0.05 to 1.42) 0.55 (0.22)/0.55 (0.11 to 1.08) 0.610 0.59 (0.35)/0.53 (0.10 to 1.37) 0.59 (0.23)/0.59 (0.18 to 1.11) 0.599
SD: Standard deviation; D: Diopters; IOL: Intraocular lens; UDVA: Uncorrected distance visual acuity (logMAR); CDVA: Corrected distance visual acuity (logMAR); 
UNVA: Uncorrected near visual acuity (logMAR); DCNVA: Distance-corrected near visual acuity (logMAR); CNVA: Corrected near visual acuity (logMAR); UIVA: 
Uncorrected intermediate visual acuity (logMAR); CIVA: Corrected intermediate visual acuity (logMAR); DCIVA: Distance-corrected intermediate visual acuity (logMAR).
Figure 1 Mean defocus curve in bifocal and trifocal groups.
Figure 2 Mean contrast sensitivity function in bifocal and trifocal 
groups at 6 (A) and 12mo (B) after surgery.
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DISCUSSION
Our research group reported in a previous study a comparative 
analysis of the outcomes obtained with the AT LISA bifocal 
and trifocal IOLs at 3mo after surgery[14]. As in the current 
study, we obtained no significant differences with the two types 
of diffractive IOLs in UDVA and CDVA[14]. Therefore, the two 
IOLs evaluated provide a good and comparable distance visual 
outcome. These results are also consistent with those obtained 
in previous studies evaluating each type of IOL[1-4,6,8,12-14]. 
Concerning near vision, we have found significant differences 
among the bifocal and trifocal implant, as in our previous 
comparative study[14]. Specifically, significantly better CNVA 
was obtained with the trifocal IOL compared to the bifocal 
IOL at 6 and 12mo after surgery. Likewise, UNVA measured at 
33 cm and DCNVA measured at 33 and 40 cm were 
significantly better in the trifocal group at 6mo, but not at 12mo. 
In our previous comparative study at 3mo postoperatively[14], 
better UNVA, CNVA and DCNVA were obtained with the 
trifocal IOL compared to the bifocal IOL. Therefore, it seems 
that the initial UNVA and DCNVA outcomes are better with 
the trifocal IOL, but with time become comparable to those 
obtained with the bifocal IOL. The residual refraction seems to 
play a major role on this finding. As in our previous study[14], 
the residual cylinder was significantly higher in the group of 
eyes implanted with the bifocal IOL and it has been shown that 
small amounts of residual astigmatism in eyes implanted with 
diffractive IOLs can induce significant levels of degradation 
of the visual quality[19]. The use of a larger incision (2.2 mm) 
for the insertion of the bifocal IOL may be the reason for 
the larger manifest cylinder found in the bifocal group. At 
6mo postoperatively, postoperative corneal astigmatism was 
slightly higher in the bifocal group, but the difference with the 
trifocal group did not reach statistical significance. Previous 
studies have a shown a trend to higher corneal cylinder in the 
initial postoperative period when 2.2 mm corneal incision 
is used in cataract surgery compared to the use of 1.8-mm 
microincision[20-21]. Regarding the visual outcomes obtained 
in our sample, better distance-corrected visual acuities were 
obtained under monocular conditions (shown in Tables) 
compared to those obtained binocularly (shown in the defocus 
curve), which is consistent with previous studies reporting 
this beneficial contribution of both eyes to the binocular visual 
performance when implanted with diffractive multifocal 
IOLs[22].
In agreement with the outcomes obtained in optical bench 
simulation studies[15-16], the trifocal IOL provided significantly 
better intermediate visual outcomes which confirms that a third 
effective focus is provided by this optical design. Specifically, 
UIVA and DCIVA were significantly better at 6 and 12mo 
after surgery with the trifocal IOL compared to the bifocal. 
In previous comparative studies[13-14], significantly better 
UIVA and DCIVA values have been reported in the initial 
postoperative period after the implantation of the same trifocal 
IOL compared to the bifocal. The superiority of the trifocal 
over the bifocal IOL in terms of visual outcome was also found 
in our series in the analysis of the 12-month postoperative 
binocular defocus curve. Specifically, significantly better visual 
acuity in the trifocal group compared to the bifocal group 
was found for the defocus levels of -1.00 and -1.50 D that 
correspond to the vergence demands of intermediate vision. 
Similarly, other authors have found in the initial postoperative 
period better visual outcome in the intermediate range of 
defocus for the trifocal IOL compared to the bifocal[12-14]. In 
our series, the 12-month distance-corrected visual acuity for 
the defocus of -3.00, -3.50 and -4.00 D was significantly better 
in the bifocal group, suggesting that the bifocal IOL provides 
a near focus closer to the eye than the trifocal IOL. It should 
be considered that although the two IOLs evaluated were 
diffractive, the light distribution provided by the diffractive 
platform is different.
To evaluate the potential impact of trifocality on visual 
and ocular optical quality, contrast sensitivity and ocular 
higher order aberrations were also measured in the current 
series. Some differences of small magnitude but statistically 
significant were found for 6-month postoperative photopic 
contrast sensitivity values for the spatial frequency of 3 cycles/
degree and mesopic contrast sensitivity values for the spatial 
frequencies of 6 and 12 cycles/degree. However, no significant 
differences in contrast sensitivity among groups were detected 
at the end of the follow-up, as in other studies comparing both 
IOLs but in a shorter term[12,14]. This is consistent with the 
absence of significant differences in CDVA during the follow-
up. The presence of some differences between IOLs for low 
and medium spatial frequencies at 6mo may be attributable to 
several factors such as inherent intra-individual variability or 
the potential impact of the development of some level of PCO 
during the follow-up in some cases. In our series, mean EPCO 
scores at 12mo postoperatively were 0.49±0.67 and 0.33±0.47 
in the bifocal and trifocal groups, respectively. These values are 
similar to those reported in previous series evaluating the same 
type of IOL[3]. A total of 11.4% and 7.5% of eyes developed 
significant PCO in the bifocal and trifocal IOL groups, 
respectively, being necessary a YAG capsulotomy. When our 
contrast sensitivity outcomes are compared to those reported 
in other studies using the same method of measurement, they 
are better than those obtained with refractive multifocal IOLs 
and similar to those obtained with other diffractive bifocal IOLs[23-24]. 
However, as expected, our contrast sensitivity outcomes are 
somewhat more limited than those obtained with monofocal 
IOLs[23-24]. This is coherent as diffractive IOLs distribute light 
to different foci, reducing the level of contrast that is present in 
each of them[25].   
This paper has some limitations that should be acknowledged. 
First, an intra-individual design may have been a better option 
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for our study, but unfortunately this design was not possible 
in our center when the study was conducted. Likewise, the 
relevance of the comparison may have been increased if the 
bifocal plate haptic IOL AT.LISA with the same IOL body 
design and the same injection protocol would have been used. 
Third, pupil size was not measured in this study and therefore 
we cannot characterize accurately the real impact of this factor 
on the visual outcomes obtained. These limitations must be 
considered for improving and optimizing future comparative 
studies of bifocal and trifocal IOLs.
In conclusion, an effective distance, intermediate and near 
visual rehabilitation can be achieved after cataract surgery with 
implantation of a trifocal diffractive IOL, with the advantage 
of maintaining levels of visual quality comparable to those 
obtained with diffractive bifocality. An improved intermediate 
visual outcome is obtained with the trifocal IOL compared to 
the bifocal IOL during the first 12mo after its implantation.
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